ProPhase Labs, Inc. (NASDAQ:PRPH) reported Q2 2017 earnings this N/A, coming in at ($0.09) per share, missing Wall Street’s estimates of N/A per Share. Revenue for the quarter came in at $1.91 million missing the streets estimates
Analyst Coverage For ProPhase Labs, Inc. (NASDAQ:PRPH)
These are No ratings tracked in the last 12 months. .
The current consensus rating for ProPhase Labs, Inc. (NASDAQ:PRPH) is N/A (Score: NaN) with a consensus target price of N/ARecent Insider Trading for ProPhase Labs, Inc. (NASDAQ:PRPH)
- On 6/4/2015 Ted William Karkus, Major Shareholder, bought 200,000 with an average share price of $1.30 per share and the total transaction amounting to $260,000.00.
- On 5/19/2015 Ted William Karkus, CEO, bought 210,000 with an average share price of $1.35 per share and the total transaction amounting to $283,500.00.
- On 11/7/2014 Braden Michael Leonard, Major Shareholder, bought 64,746 with an average share price of $1.34 per share and the total transaction amounting to $86,759.64.
- On 10/9/2014 Braden Michael Leonard, Major Shareholder, bought 284,885 with an average share price of $1.30 per share and the total transaction amounting to $370,350.50.
- On 10/8/2014 Braden Michael Leonard, Major Shareholder, bought 114,910 with an average share price of $1.30 per share and the total transaction amounting to $149,383.00.
- On 10/2/2014 Braden Michael Leonard, Major Shareholder, bought 16,900 with an average share price of $1.40 per share and the total transaction amounting to $23,660.00.
Recent Trading for ProPhase Labs, Inc. (NASDAQ:PRPH) Shares of ProPhase Labs, Inc. closed the previous trading session at 2.07 up +0.03 1.47% with 12,045 shares trading hands.